COMMONWEALTH EQUITY SERVICES, LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$239,000
-41.6%
97,584
-3.0%
0.00%0.0%
Q2 2021$409,000
-6.6%
100,584
+3.4%
0.00%0.0%
Q1 2021$438,000
-6.4%
97,234
+2.1%
0.00%0.0%
Q4 2020$468,000
-16.1%
95,234
+1.1%
0.00%
-50.0%
Q3 2020$558,000
+128.7%
94,234
+2.5%
0.00%
+100.0%
Q2 2020$244,000
+1184.2%
91,934
+819.3%
0.00%
Q1 2020$19,00010,0000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders